Hyperfine (HYPR) EBITDA Margin (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,440.00 |
| Dec 31, 2025 | 11,466.00 |
| Sep 30, 2025 | 9,637.00 |
| Jun 30, 2025 | 15,426.00 |
| Mar 31, 2025 | -4,635.00 |
| Dec 31, 2024 | -16,288.00 |
| Sep 30, 2024 | -223.00 |
| Jun 30, 2024 | 2,451.00 |
| Mar 31, 2024 | 10,973.00 |
| Dec 31, 2023 | 7,173.00 |
| Sep 30, 2023 | -15,886.00 |
| Jun 30, 2023 | 14,887.00 |
| Mar 31, 2023 | 46,241.00 |
| Dec 31, 2022 | -39,142.00 |
| Sep 30, 2022 | 94,718.00 |
| Jun 30, 2022 | 6,243.00 |
| Mar 31, 2022 | 440,798.00 |
| Dec 31, 2021 | -156,547.00 |
| Sep 30, 2021 | -34,349.00 |
| Jun 30, 2021 | -171,630.00 |